IPOGrid
0001697834
IPO filing research

Stem Holdings, Inc.

Medicinal Chemicals & Botanical Products

follow-on priced 424B3

Stem Holdings, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: 424B3 on 2021-04-20.

Filing Timeline

SEC EDGAR
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2021-04-20 · 0001493152-21-009167
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2021-04-16 · 9999999995-21-001464
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2021-04-12 · 9999999995-21-001387
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2021-04-05 · 0001493152-21-008017
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2021-03-10 · 0001493152-21-005741
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2021-03-01 · 0001493152-21-005041
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2021-02-12 · 0001493152-21-003715
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior EFFECT filing.
2021-02-05 · 0001493152-21-002783
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2021-02-02 · 9999999995-21-000384
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-4/A filing.
2021-01-19 · 0001493152-21-001354
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior S-1 filing.
2021-01-14 · 0001493152-21-000988
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-4 in the pre-IPO sequence.
2021-01-05 · 0001493152-21-000194
S-4 filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows EFFECT in the pre-IPO sequence.
2020-12-28 · 0001493152-20-024314
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2020-11-04 · 9999999995-20-003082
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2020-10-26 · 9999999995-20-002969
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2020-10-21 · 0001493152-20-019752
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2020-07-21 · 0001493152-20-013691
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1 and marks the registration effective.
2020-07-02 · 9999999995-20-001632
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
First tracked pre-IPO filing for this issuer.
2020-06-17 · 0001493152-20-011329
Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+9.1%
Median day-1
60%
Above issue
+0.7%
Median week-1
-20.9%
Downside (p10)
BlossomHill Therapeutics, Inc. BLSM
2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%
same SIC grouprecent IPO
Latigo Biotherapeutics, Inc. LTGO
2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%
same SIC grouprecent IPO
Braveheart Bio, Inc. BRVE
2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%
same SIC grouprecent IPO
Attovia Therapeutics, Inc. ATTO
2026-08-05 $269M Day 1: +28.8% Wk 1: +18.6%
same SIC grouprecent IPO
Apnimed, Inc. APMD
2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%
same SIC grouprecent IPO
Scribe Therapeutics, Inc. SCTX
2026-07-24 $129M Day 1: +44.3% Wk 1: +37.2%
same SIC grouprecent IPO
Standard Nuclear, Inc. STDN
2026-07-16 $150M Day 1: -8.2% Wk 1: -37.2%
same SIC grouprecent IPO
Kardigan, Inc. KARD
2026-06-18 $400M Day 1: +37.5% Wk 1: +41.1%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.